Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RYTM
#1011
Rhythm Pharmaceuticals, Inc. Common Stock
92.730
0
-4.28%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-4.28%
Monthly Change
-11.82%
6 month change
-15.94%
Cambio anual
-15.94%
Cierres anteriores
96.880
0
Open
92.830
0
Bid
Ask
Low
92.730
0
High
92.830
0
Volumen
161
Markets
Acciones
Atención Sanitaria
RYTM
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
50.18 M
50.33 M
56.75 M
60.14 M
63.22 M
68.29 M
—
Valuation ratios
Enterprise value
1.39 B
443.04 M
1.5 B
2.65 B
3.45 B
7.25 B
21.27 B
Price to earnings ratio
—
-7.13
-8.25
-14.1
-12.9
-34.42
-107.08
Price to sales ratio
—
156.95
63.15
33.62
26.24
—
—
Price to cash flow ratio
—
3.39
8.61
19.12
29.98
60.13
184.39
Price to book ratio
—
1.74
5.65
15.33
157.14
50.02
179.92
Enterprise value to EBITDA ratio
—
-2.61
-8.19
-13.05
-11.72
—
—
Profitability ratios
Return on assets %
0.72
0.21
0.47
0.56
0.66
0.41
0.46
Return on equity %
0.8
0.24
0.69
1.09
11.99
1.41
7.23
Return on invested capital %
11.27 K
4 279.65
3 215.48
2 584.26
2 491.51
1 914.72
1 057.99
Gross margin %
—
81.01
90.98
87.99
89.73
89.73
358.31
Operating margin %
—
5 391.85
757.92
238.1
204.04
101.19
421.96
EBITDA margin %
—
-5 376.82
-773.17
-262.61
-226.26
-127
—
Net margin %
—
2 207.1
766.22
238.52
200.27
103.57
433.6
Liquidity ratios
Quick ratio
—
7.1
8.83
5.43
3.08
4.16
14.47
Current ratio
10.1
7.1
8.9
5.58
3.24
4.41
15.24
Inventory turnover
—
5.4
1.41
1.61
0.98
0.88
0.95
Asset turnover
0
0.01
0.07
0.22
0.36
0.43
0.44
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.28
0.21
0.98
Long term debt to total equity ratio
—
—
—
—
4.98
0.73
16.02
Per share metrics
Operating cash flow per share
—
2.94
3.33
2.36
1.87
1.78
1.8
EBIT per share
—
-3.44
-3.52
-3.54
-4.84
-3.72
-2.98
EBITDA per share
—
-3.42
-3.51
-3.53
-4.83
-3.71
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
5.94
6.39
4.78
5.26
5.98
21.82
Net current asset value per share
—
6.22
6.8
5.35
6.13
7.19
26.17
Tangible book value per share
—
5.63
4.92
2.82
0.26
2.06
4.52
Working capital per share
—
5.34
6.03
4.39
4.24
5.55
19.16
Book value per share
—
5.73
5.07
2.94
0.36
2.14
4.87
Noticias
Guggenheim raises Rhythm Pharmaceuticals stock price target on guidance
Citizens eleva el precio objetivo de Rhythm Pharmaceuticals ante aprobación
Citizens eleva precio objetivo de Rhythm Pharmaceuticals por aprobación HO
Citizens raises Rhythm Pharmaceuticals stock price target on HO approval outlook
Stifel reitera recomendación de Compra en Rhythm Pharmaceuticals con objetivo de 131 dólares
Stifel reitera compra en Rhythm Pharmaceuticals con objetivo de $131
Stifel reiterates Buy on Rhythm Pharmaceuticals stock, $131 target
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
Rhythm Pharma T4 2025: ingresos superan expectativas y lanzamiento HO cerca
Rhythm Pharma Q4 2025 slides: revenue beats as HO launch nears
Rhythm Pharma superaron 0.09$ las previsiones de BPA en el cuarto trimestre del año
Rhythm Pharma supera por 0,09$ las previsiones de BPA en el cuarto trimestre del año